Giovanni Barillari1, Ambrogio P Londero2, Benjamin Brenner3, Dolores Nauffal4, Juan Francisco Sánchez Muñoz-Torrero5, Fátima Del Molino6, Farès Moustafa7, Olga Madridano8, Francisco Martín-Martos9, Manuel Monreal10. 1. Center for Haemorrhagic and Thrombotic Disorders, Udine General and University Hospital, Udine, Italy. Electronic address: barillarigiovanni@yahoo.it. 2. Clinic of Obsterics and Gynecology, DISM, University of Udine, Udine, Italy; Unit of Obstetrics and Gynecology, Saint Polo's Hospital, Monfalcone, Italy. 3. Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Israel; Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel. 4. Department of Pneumonology, Hospital Universitario La Fe, Valencia, Spain. 5. Department of Internal Medicine, Hospital San Pedro de Alcántara, Cáceres, Spain. 6. Department of Internal Medicine, Hospital General de Catalunya, Department of Internal Medicine, Clínica del Vallés, Barcelona, Spain. 7. Department of Emergency, Clermont-Ferrand University Hospital, Clermont-Ferrand, France. 8. Department of Internal Medicine, Hospital Infanta Sofía, Madrid, Spain. 9. Department of Internal Medicine, Hospital General Universitario Santa Lucía, Murcia, Spain. 10. Department of Internal Medicine, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain.
Abstract
INTRODUCTION: The aim of this study was to investigate the recurrence rate of venous thromboembolism (VTE) and the prevalence of major bleeding or death in patients with previous VTE in pregnancy and puerperium. Risk factors for VTE recurrence were also assessed. MATERIALS AND METHODS: We evaluated a cohort of patients enrolled in the international, multicenter, prospective Registro Informatizado de la Enfermedad Trombo-Embólica (RIETE) registry with objectively confirmed VTE. RESULTS: In the registry, 607 women were presenting with VTE that occurred during pregnancy or puerperium. The 2-year VTE recurrence rate was 3.3% (CI: 95 1.5-5.0%) and the recurrent VTE incidence rate was 2.28events/100 patients-year. Among the 16 cases of VTE recurrence 11 cases appeared during drug treatment while only five cases were diagnosed after therapy discontinuation. No significant difference was found in treatment duration among these two subgroups of VTE recurrence cases and women without recurrence. Furthermore, the use of thrombolytics and inferior vena cava filter in initial treatment was associated to an increased risk of VTE recurrence. CONCLUSIONS: The current study provides new insights on VTE recurrence rate in patients with deep vein thrombosis (DVT) or pulmonary embolism (PE) that occurred in pregnancy or postpartum period. These findings can contribute to risk assessment of thrombotic burden, thereby allowing for better decision making regarding antithrombotic management in this clinical setting.
INTRODUCTION: The aim of this study was to investigate the recurrence rate of venous thromboembolism (VTE) and the prevalence of major bleeding or death in patients with previous VTE in pregnancy and puerperium. Risk factors for VTE recurrence were also assessed. MATERIALS AND METHODS: We evaluated a cohort of patients enrolled in the international, multicenter, prospective Registro Informatizado de la Enfermedad Trombo-Embólica (RIETE) registry with objectively confirmed VTE. RESULTS: In the registry, 607 women were presenting with VTE that occurred during pregnancy or puerperium. The 2-year VTE recurrence rate was 3.3% (CI: 95 1.5-5.0%) and the recurrent VTE incidence rate was 2.28events/100 patients-year. Among the 16 cases of VTE recurrence 11 cases appeared during drug treatment while only five cases were diagnosed after therapy discontinuation. No significant difference was found in treatment duration among these two subgroups of VTE recurrence cases and women without recurrence. Furthermore, the use of thrombolytics and inferior vena cava filter in initial treatment was associated to an increased risk of VTE recurrence. CONCLUSIONS: The current study provides new insights on VTE recurrence rate in patients with deep vein thrombosis (DVT) or pulmonary embolism (PE) that occurred in pregnancy or postpartum period. These findings can contribute to risk assessment of thrombotic burden, thereby allowing for better decision making regarding antithrombotic management in this clinical setting.
Authors: E K Abdalhabib; A Alfeel; E I Ali; I K Ibrahim; A A Mobarki; G Dobie; H A Hamali; M Saboor Journal: Balkan J Med Genet Date: 2022-06-05 Impact factor: 0.810